{"schema_version":"secwatch.filing_event.v1","accession":"0001447028-24-000061","form_type":"8-K","ticker":"ABUS","cik":"0001447028","company_name":"Arbutus Biopharma Corp","filed_at":"2024-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.458599+00:00","generated_at":"2026-06-01T07:57:24.516630+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Arbutus shareholders approve 9.5M share increase under 2016 Omnibus Plan","bullets":["Amendment increases aggregate authorized shares by 9,500,000 common shares.","All seven director nominees (Torti, McElhaugh, Burgess, Henriques, Manchester, Meyers, Rewolinski) elected.","Non-binding advisory vote on named executive officer compensation approved (99.3M for, 13.5M against).","Ernst & Young LLP appointed as independent auditor for FY 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001447028-24-000061","json":"https://secwatch.observer/filing/0001447028-24-000061.json","markdown":"https://secwatch.observer/filing/0001447028-24-000061.md","text":"https://secwatch.observer/filing/0001447028-24-000061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000061/0001447028-24-000061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000061/abus-20240522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:57:24.516630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}